These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37160674)

  • 1. Antitrust as a Guardrail for Socially Responsible Neurotechnology Design.
    Nadler R
    Can J Neurol Sci; 2023 Jun; 50(s1):s42-s45. PubMed ID: 37160674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Korea Neuroethics Guidelines.
    Yoo SH; Choi K; Nam S; Yoon EK; Sohn JW; Oh BM; Shim J; Choi MY
    J Korean Med Sci; 2023 Jun; 38(25):e193. PubMed ID: 37365727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Anticipatory Approach to Ethico-Legal Implications of Future Neurotechnology.
    Rainey S
    Sci Eng Ethics; 2024 May; 30(3):18. PubMed ID: 38748291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Neurotech Start-Ups Envision Ethical Futures: Demarcation, Deferral, Delegation.
    Knopf S; Frahm N; M Pfotenhauer S
    Sci Eng Ethics; 2023 Feb; 29(1):4. PubMed ID: 36729246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An XYZ-axis Matrix Approach for the Integration of Neuroscience and Neuroethics.
    Jwa AS; Shim J; Choi S; Eom J; Kim S; Ryu YJ
    Exp Neurobiol; 2023 Feb; 32(1):8-19. PubMed ID: 36919332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. East Asian perspective of responsible research and innovation in neurotechnology.
    Fukushi T
    IBRO Neurosci Rep; 2024 Jun; 16():582-597. PubMed ID: 38774060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health Care Efficiencies: Consolidation and Alternative Models vs. Health Care and Antitrust Regulation - Irreconcilable Differences?
    King MW
    Am J Law Med; 2017 Nov; 43(4):426-467. PubMed ID: 29452560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimensions of Ethical Direct-to-Consumer Neurotechnologies.
    Kreitmair KV
    AJOB Neurosci; 2019; 10(4):152-166. PubMed ID: 31642755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care consolidation and the changing health care marketplace. A review of the literature and issues.
    Goldberg LG
    EBRI Issue Brief; 1999 Oct; (214):1-15. PubMed ID: 10622866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commercial biobanks and genetic research: ethical and legal issues.
    Anderlik M
    Am J Pharmacogenomics; 2003; 3(3):203-15. PubMed ID: 12814328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain Recording, Mind-Reading, and Neurotechnology: Ethical Issues from Consumer Devices to Brain-Based Speech Decoding.
    Rainey S; Martin S; Christen A; Mégevand P; Fourneret E
    Sci Eng Ethics; 2020 Aug; 26(4):2295-2311. PubMed ID: 32356091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manipulating Memories: The Ethics of Yesterday's Science Fiction and Today's Reality.
    Robillard JM; Illes J
    AMA J Ethics; 2016 Dec; 18(12):1225-1231. PubMed ID: 28009249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concerns in the Blurred Divisions between Medical and Consumer Neurotechnology.
    Paek AY; Brantley JA; Evans BJ; Contreras-Vidal JL
    IEEE Syst J; 2021 Jun; 15(2):3069-3080. PubMed ID: 35126800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Perceived Value of Neuroethics Questions and Policy to Neuro-Entrepreneurs.
    Moss AU; Li ZR; Rommelfanger KS
    Front Neurosci; 2021; 15():702019. PubMed ID: 34720850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroethics of Neuromodulation: An Update.
    Zuk P; Torgerson L; Sierra-Mercado D; Lázaro-Muñoz G
    Curr Opin Biomed Eng; 2018 Dec; 8():45-50. PubMed ID: 30687802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gray Matters: Exploring Technologists' Perceptions of Dual-Use Potentiality in Emerging Neurotechnology Applications.
    Butorac I; Lentzos F; Aicardi C
    Health Secur; 2021; 19(4):424-430. PubMed ID: 34264762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroethics guidance documents: principles, analysis, and implementation strategies.
    O'Shaughnessy MR; Johnson WG; Tournas LN; Rozell CJ; Rommelfanger KS
    J Law Biosci; 2023; 10(2):lsad025. PubMed ID: 37901886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.